Abacavir sulfate

This classification denotes a reverse transcriptase inhibitor, in sulfate form, with the molecular formula 2C14H18N6O.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J220T4J9Q2, chemically known as 2-cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-, sulfate (salt)(2:1), (1s,4r)- but more generally known as abacavir sulfate, which bears US NIH Compound Identifier 65141. The base compound, abacavir, also appears in succinate form, and is sometimes combined with lamivudine and zidovudine. European Medicines Agency schedules Abacavir sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00231MIG. Most nations, for tariff and trade purposes, schedule abacavir sulfate under HS 29335995 and SITC 51576. As of Q4 2014, ABACAVIR SULFATE remains US FDA's Preferred Term for this commodity. Abacavir sulfate bears US NLM identifiers UMLS ID C0724515 and NCI Concept Code C28804. SMILES: C1NC2C(NC(NC2N1[C@@H]3C[C@@H](C=C3)CO)N)NC4CC4.C1NC2C(NC(NC2N1[C@@H]3C[C@@H](C=C3)CO)N)NC4CC4.OS(=O)(=O)O.